Zuellig Pharma Asia Pacific You started the Chinese operations and have been working in the country for many years but recently moved up to running all operations in Asia Pacific. Are you still closely involved with what’s happening in China? I started the operations in China almost 16 years ago, and I started them…
Shire Deutschland The acquisition of Jerini has to be one of the biggest milestones for Shire Deutschland in its recent history. How have the synergies developed between the two companies, and how is the integration progressing? To quote Dr Werner Föller, head of Shire Deutschland’s Human Genetic Therapies Business Unit, “The integration…
Grünenthal You arrived at Grünenthal fairly recently, in January of this year. What was it about the company that attracted you to the position? That goes back to 1987, when I made up my mind what my high school major and college degree was going to be. At that time, Germany…
Roche France Roche has a long history in France and currently enjoys a higher position than its worldwide ranking. Can you elaborate on the importance of this market for the group overall? The affiliate in France is one of the largest European affiliate and historically we have held a strong presence through…
Ipsen France As the G5 brings together five very different companies – Ipsen, LFB, Pierre Fabre, Sanofi-Aventis, Servier – could you explain the origin behind the creation and the purpose of the group today? The pharmaceutical industry has been present in France for many years and is one of the country’s traditional…
AstraZeneca France You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of M&A activity in the industry as well as a rising generics market in France and increased regulations for market authorization. How has the business changed for AstraZeneca in this…
Biogen Idec Germany Having experienced many years at big pharmaceutical companies, you recently moved into the booming biotech sector by joining Biogen Idec in 2007. What made you make such a decision? The growth potential of the biotech industry is incomparable to any other sector in the pharmaceutical industry, and the entire industry…
GSK France France yet today you work for a foreign multinational within France. Can you speak to the differences in culture and what the transition has been like? I have spent half of my career abroad but always having worked for a French pharmaceutical company whether it was Fournier or sanofi-aventis. Of…
Dr. F. Köhler Chemie Your father was the founder of Dr. Franz Köhler Chemie – that carries his name – and was a very well respected doctor among the German medical and pharmaceutical community. What have been the main challenges you faced when taking over the company 25 years ago and becoming its General…
LEEM - Les Enterprises du Medicament What are the main tasks of the LEEM? The LEEM is the only professional organization representing the pharmaceutical industry in France. It includes almost all companies which seek to develop, manufacture and market drugs. Leem represents all components of the profession: international groups, medium-sized companies, an important fabric of small,…
FPS - Facophar Santé FPS is a hundred year old organization with roots in the beginning of the last century representing today SME suppliers to the health industries. Given the variety of its membership what are the current priorities of FPS and how does the organization stay relevant to its multiple industries? Firstly I…
LEEM - Les Enterprises du Medicament Throughout your prolific career in the pharmaceutical industry, what would you describe have been the major changes in the French pharmaceutical market and to what extent has France kept up? I think France has kept up with the world market albeit with some notable differences, namely in terms of our…
See our Cookie Privacy Policy Here
